Major Break Throughs

     Ind-Swift has filed more than 680 dossiers for registration in more than 20 Countries around the world stretching from South America to Philippines.
     It has developed Netazoxanide Anti-Diarrheal drug for the first time in India after successful clinical trials and bio-equivalence studies.
     It has strong capacity to develop non infringing API's requiring Complex Chemistry and Multiple reactions.
     Ind-Swift has developed taste masking technology of macrolides for the first time in India.
     Ind-Swift has developed the sustained release process of Isoxsuprine HCL tablets for the first time in India.
     Ind-Swift has developed the dissolving tablet technique.